Department of Health and Human Services November 18, 2021 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
Discovery Therapeutics, LLC, et al.; Withdrawal of Approval of 18 Abbreviated New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 18 abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-July Through September 2021
This quarterly notice lists CMS manual instructions, substantive and interpretive regulations, and other Federal Register notices that were published from July through September 2021, relating to the Medicare and Medicaid programs and other programs administered by CMS.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.